BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32084069)

  • 1. Myositis-Specific Antibodies and Myositis-Associated Antibodies in Patients With Idiopathic Inflammatory Myopathies From the PANLAR Myositis Study Group.
    González-Bello Y; Garcia-Valladares I; Reyes-Pérez IV; García-Cerda D; Medrano-Ramírez G; Navarro-Zarza JE; Andrade-Ortega L; Maradiaga-Ceceña M; Cardenas-Anaya A; Nava-Zavala AH; Orozco-Barocio G; Vázquez-Del Mercado M; Rojo-Mejia A; Loyo E; Gottschalk P; Iglesias-Gamarra A; Vega K; Rojas C; Mantilla R; Gómez G; García-Kutzbach A; Fritzler MJ; García-De La Torre I
    J Clin Rheumatol; 2021 Dec; 27(8):e302-e306. PubMed ID: 32084069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.
    Gupta L; Naveen R; Gaur P; Agarwal V; Aggarwal R
    Semin Arthritis Rheum; 2021 Feb; 51(1):113-120. PubMed ID: 33360322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology.
    Gómez GN; Pérez N; Braillard Poccard A; Gómez RA; Costi AC; García MA; Viola M; Benitez A; Aciar MM; Crespo Espíndola M; Yucra D; Cosatti MA; Pisoni C; Capelusnik D; Lojo MN; Barrios BI; Rivero M; Kisluk B; Granel A
    Clin Rheumatol; 2021 Nov; 40(11):4473-4483. PubMed ID: 34159491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
    Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111
    [No Abstract]   [Full Text] [Related]  

  • 5. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
    Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
    Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
    Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
    Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
    Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N;
    J Autoimmun; 2019 Jul; 101():48-55. PubMed ID: 30992170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myositis autoantibodies detected by line blot immunoassay: clinical associations and correlation with antibody signal intensity.
    Loarce-Martos J; Calvo Sanz L; Garrote-Corral S; Ballester González R; Pariente Rodríguez R; Rita CG; García-Soidan A; Bachiller-Corral J; Roy Ariño G
    Rheumatol Int; 2023 Jun; 43(6):1101-1109. PubMed ID: 36763166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies.
    Ghirardello A; Gatto M; Franco C; Zanatta E; Padoan R; Ienna L; Gallo N; Zen M; Lundberg IE; Mahler M; Doria A; Iaccarino L
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of idiopathic inflammatory myopathies with novel myositis-specific autoantibodies.
    Rams A; Kosałka-Węgiel J; Kuszmiersz P; Matyja-Bednarczyk A; Polański S; Zaręba L; Bazan-Socha S
    Adv Clin Exp Med; 2021 Dec; 30(12):1239-1248. PubMed ID: 34610217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires.
    Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF
    Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study.
    Montagnese F; Babačić H; Eichhorn P; Schoser B
    J Neurol; 2019 Jun; 266(6):1358-1366. PubMed ID: 30840145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.
    Aguila LA; Lopes MR; Pretti FZ; Sampaio-Barros PD; Carlos de Souza FH; Borba EF; Shinjo SK
    Clin Rheumatol; 2014 Aug; 33(8):1093-8. PubMed ID: 24989017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis.
    Ukichi T; Yoshida K; Matsushima S; Kawakami G; Noda K; Furuya K; Kurosaka D
    RMD Open; 2019; 5(1):e000850. PubMed ID: 30997152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myositis autoantibodies in Iranian myositis patients: assessment the frequency and clinical relevancy.
    Ebrahimi M; Rostamian A; Rafiei-Latianee R; Najafizadeh SR; Movaseghi S; Faezi ST; Ghazanfari T
    Clin Rheumatol; 2022 Feb; 41(2):533-539. PubMed ID: 34514533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-mitochondrial antibodies in Indian patients with idiopathic inflammatory myopathies.
    Gaur PS; R N; Anuja AK; Singh MK; Rai MK; Muhammed R; Sahu AK; Agarwal V; Gupta L
    Int J Rheum Dis; 2022 Jun; 25(6):659-668. PubMed ID: 35384316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
    J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
    Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
    Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of myositis autoantibodies in Chinese patients with cancer-associated myositis.
    Li L; Liu C; Wang Q; Wu C; Zhang Y; Cheng L; Wen X; Zeng X; Zhang F; Li Y
    J Clin Lab Anal; 2020 Aug; 34(8):e23307. PubMed ID: 32222002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.